NHFG
IRWD icon

New Harbor Financial Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

New Harbor Financial Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-716
Closed -$6K – 133
2015
Q3 		$6K Hold
716
– – 0.01% 100
2015
Q2 		$7K Hold
716
– – 0.01% 88
2015
Q1 		$10K Hold
716
– – 0.01% 74
2014
Q4 		$9K Buy
+716
New +$8.19K 0.01% 73
2014
Q3 		– Sell
-1,910
Closed -$25K – 58
2014
Q2 		$25K Buy
+1,910
New +$20.8K 0.03% 61

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

New Harbor Financial Group's IRWD Position: Q4 2015 in Review

New Harbor Financial Group sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2015, closing a stake of 716 shares — an estimated $6K sold.

New Harbor Financial Group first reported a position in IRWD in Q2 2014 and held it in 5 quarters. The position peaked at $25K in Q2 2014. 137 funds tracked by Wall St. Rank hold IRWD as of Q4 2015.

  • New Harbor Financial Group reported no remaining Ironwood Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • New Harbor Financial Group sold 716 Ironwood Pharmaceuticals shares in Q4 2015, an estimated $6K.
  • New Harbor Financial Group first reported a position in Ironwood Pharmaceuticals in Q2 2014 and held it in 5 quarters.
  • New Harbor Financial Group's Ironwood Pharmaceuticals position peaked at $25K in Q2 2014.
  • 137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2015.

Based on New Harbor Financial Group's 13F filing for Q4 2015, filed 1 Feb 2016.